Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Remote Self-monitoring of Blood Glucose (SMBG) Combined With the Promotion and Application of Internet Mobile Terminal (APP) on the Improvement of the Staged Type 2 Diabetes Mellitus (T2DM) Management and the Success Rate of Blood Glucose in the Community

NCT03588000 is registered in ClinicalTrials.gov with Yuwen Zhang as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03588000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Remote Self-monitoring of Blood Glucose (SMBG) Combined With the Promotion and Application of Internet Mobile Terminal (APP) on the Improvement of the Staged Type 2 Diabetes Mellitus (T2DM) Management and the Success Rate of Blood Glucose in the Community
Lead sponsor
Yuwen Zhang
Phase
Not applicable
Overall status
Completed
Start date
November 23, 2018
Completion date
April 16, 2021
Enrollment
498 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.